Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro. (2021)
Attributed to:
PRH/HHEX in intrahepatic cholangiocarcinoma, disease progression and response to chemotherapeutics.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21873/anticanres.15435
PubMed Identifier: 34848470
Publication URI: http://europepmc.org/abstract/MED/34848470
Type: Journal Article/Review
Volume: 41
Parent Publication: Anticancer research
Issue: 12
ISSN: 0250-7005